---

---

India Globalization Capital Inc.

IGC 4 | $0.4392 -0.2% 0.0% 480K |

Health Technology

(0.0% 1d) (29.6% 1m) (32.1% 1y) (0.0% 2d) (0.0% 3d) (-17.3% 7d) (-57.34% volume)
Earnings Calendar:
Market Cap: $ 27,992,166
http://www.igcinc.us
Sec Filling | Patents | 50 employees


India Globalization Capital, Inc. engages in the development and commercialization of cannabinoid based alternative therapies for indications such as Alzheimer's disease, Parkinson's disease, and pain. It operates through the Infrastructure Business and Life Sciences segments. The Infrastructure Business segment involves the rental of heavy construction equipment, execution of construction contracts, and purchase and reseal of physical commodities used in infrastructure. The Life Sciences segment includes a biotech component, and a vertically integrated hemp-cannabinoid based healthcare and wellness business, which involves the production of plant and cannabinoid-based products, and therapies. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Potomac, MD.

alzheimer   parkinson   construction   alzheimer’s  

Drugs

Hyalolex Hand Sanitizer (ALCOHOL)
Hyalolex Hand Sanitizer with Lemon and Zinc (ALCOHOL)

add to watch list Paper trade email alert is off

---

Press-releases

IGC Reports Financial Results for Third Fiscal Quarter Ended Dec. 31, 2022
Published: 2023-02-15 (Crawled : 01:00) - globenewswire.com
IGC 4 | $0.4392 -0.2% 0.0% 480K |

Health Technology

| 11.7% | O: 1.73% H: 0.0% C: -2.25%
financial

---

IGC Applauds Signing of Bipartisan Medical Marijuana and Cannabidiol Research Expansion Act
Published: 2022-12-07 (Crawled : 14:00) - globenewswire.com
IGC 4 | $0.4392 -0.2% 0.0% 480K |

Health Technology

| 7.25% | O: 1.51% H: 0.0% C: -2.24%
cannabidiol expansion research medical

---

IGC Commences Phase 2 Clinical Trials Evaluating Drug Candidate IGC-AD1 for the Treatment of Agitation in Dementia From Alzheimer’s Disease
Published: 2022-12-01 (Crawled : 13:20) - igcinc.us
IGC 4 | $0.4392 -0.2% 0.0% 480K |

Health Technology

| 18.7% | O: 7.49% H: 3.07% C: -0.35%
treatment dementia trials drug candidate disease alzheimer’s phase 2

---

IGC to Present at the RHK 2022 Disruptive Growth Conference
Published: 2022-11-30 (Crawled : 18:00) - igcinc.us
IGC 4 | $0.4392 -0.2% 0.0% 480K |

Health Technology

| 9.8% | O: 0.0% H: 1.87% C: -7.5%
conference growth

---

IGC FORM 10Q Quarter Ended September 30, 2022
Published: 2022-11-01 (Crawled : 23:00) - igcinc.us
IGC 4 | $0.4392 -0.2% 0.0% 480K |

Health Technology

| -4.52% | O: 4.33% H: 0.0% C: -10.4%

---

IGC Reports Financial Results for the Quarter Ended September 30, 2022
Published: 2022-11-01 (Crawled : 23:00) - igcinc.us
IGC 4 | $0.4392 -0.2% 0.0% 480K |

Health Technology

| -4.52% | O: 4.33% H: 0.0% C: -10.4%
financial

---

IGC Announces Results of its 2022 Annual Stockholders Meeting
Published: 2022-09-12 (Crawled : 18:00) - igcinc.us
IGC 4 | $0.4392 -0.2% 0.0% 480K |

Health Technology

| -20.46% | O: -2.21% H: 8.89% C: 6.67%
meeting results

---

IndiaGlobal8K090922 – iXBRL AS FILED
Published: 2022-09-12 (Crawled : 18:00) - igcinc.us
IGC 4 | $0.4392 -0.2% 0.0% 480K |

Health Technology

| -20.46% | O: -2.21% H: 8.89% C: 6.67%

---

IGC 8-K ASM 2022 Results AS FILED
Published: 2022-09-12 (Crawled : 18:00) - igcinc.us
IGC 4 | $0.4392 -0.2% 0.0% 480K |

Health Technology

| -20.46% | O: -2.21% H: 8.89% C: 6.67%
results

---

IGC Reports Financial Results for the Quarter Ended June 30, 2022
Published: 2022-08-08 (Crawled : 17:00) - igcinc.us
IGC 4 | $0.4392 -0.2% 0.0% 480K |

Health Technology

| -20.13% | O: 5.47% H: 1.72% C: 0.0%

---

See all

---

Your Today's Watch List

Sign in to create a watchlist

---

Gainers vs Losers

45%

55%

Top 10 Gainers

KAVL | $6.3 135.96% 57.45% 44M |

Wholesale Trade

PXMD | $0.74 79.7% 44.16% 4.5M |

Health Technology

DYNT | $0.3704 -5.27% 43.09% 5.5M |

Health Technology

LGVN P 3 d | $2.93 73.37% 42.52% 56M |

HUBC | $1.95 50.0% 32.99% 73M |

n/a

SPCB | $0.4004 45.07% 31.75% 130M |

Electronic Technology

ONVO | $1.35 33.65% 24.62% 53M |

Health Technology

OMQS | $0.7038 35.35% 24.3% 3.5M |

Professional, Scientific, and T...

SNPO | $10.54 29.48% 22.88% 3.9M |

EEIQ | $1.16 27.46% 20.86% 6.9K |

Educational Services

---

Last 48 Hours Insiders Buying

RMCF | $3.6492 2.51% -7.2% 7.1K |

Consumer Non-Durables

| 20:10

---

12 months watchlist earnings calendar

---